Research Article
Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
Figure 1
Percentage of patients compliant to treatment (logarithmic regression model, chi-square test).